Is azithromycin (Zithromax) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Azithromycin Safety in Pregnancy

Azithromycin is generally safe to use during pregnancy when clinically indicated and benefits outweigh potential risks. 1 The drug should be used for specific indications where its efficacy has been established and alternative treatments may pose greater risks.

Safety Profile

  • Azithromycin is classified as FDA Pregnancy Category B, indicating that animal reproduction studies have shown no evidence of harm to the fetus, though adequate and well-controlled studies in pregnant women are lacking 2
  • The Centers for Disease Control and Prevention (CDC) specifically recommends azithromycin for several conditions during pregnancy, including:
    • First-line treatment for chlamydial infections
    • Prophylaxis for Mycobacterium avium complex in HIV-infected pregnant women 1

Clinical Evidence Supporting Safety

  • According to North American clinical practice guidelines, azithromycin is considered safe in pregnancy with no adverse effects reported 3
  • Unlike some other antibiotics, azithromycin does not require dose adjustment during pregnancy as it does not affect the cytochrome P450 system, making it safer to use with other medications 1
  • Reproductive studies in rats and mice at doses up to 4 and 2 times the human daily dose (based on mg/m²) showed no evidence of harm to the fetus 2

Potential Concerns

  • Some studies have reported conflicting results regarding fetal and neonatal outcomes following prenatal azithromycin exposure 4
  • Concerns have been raised about potential risks including:
    • Spontaneous miscarriage
    • Major congenital malformations
    • Cardiovascular malformations
    • Preterm birth
    • Low birth weight 4

However, there is no conclusive evidence supporting these concerns, and the most recent guidelines continue to support azithromycin use when indicated 3, 1.

Specific Clinical Applications

  • Azithromycin is recommended as first-line treatment for chlamydial infections in pregnancy with a single 1g oral dose 1
  • It has been studied as part of intermittent preventive treatment in pregnancy (IPTp) for malaria, showing reduced risk of low birth weight and prematurity 5
  • Recent research demonstrates that a single 2g oral dose of azithromycin during labor significantly reduced the risk of maternal sepsis without increasing adverse events 6

Monitoring and Precautions

  • Avoid co-administration with medications that prolong QT interval due to risk of cardiac arrhythmias 1
  • Monitor for common side effects, including liver enzyme abnormalities and hearing impairment, especially when used with other medications like nelfinavir 2
  • Elderly patients may be more susceptible to torsades de pointes arrhythmia, though this is less relevant to the pregnant population 2

Conclusion for Clinical Practice

When prescribing azithromycin during pregnancy:

  1. Use only when clinically indicated for specific infections
  2. Prefer azithromycin over other antibiotics with established teratogenicity (e.g., doxycycline, fluoroquinolones)
  3. Use standard recommended dosages without adjustment for pregnancy
  4. Monitor for common side effects
  5. Avoid co-administration with QT-prolonging medications

For women with chronic conditions requiring long-term azithromycin (e.g., cystic fibrosis), the benefits of continuing treatment during pregnancy typically outweigh the potential risks of discontinuation 7.

References

Guideline

Azithromycin Use in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Concerns regarding the safety of azithromycin in pregnancy - relevance for women with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.